• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冷冻保存对人诱导多能干细胞衍生心肌细胞评估药物安全性反应特征的影响。

Effects of Cryopreservation on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Assessing Drug Safety Response Profiles.

机构信息

Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA, USA; Division of Cardiovascular Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.

Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA, USA; Division of Cardiovascular Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA; Molecular Imaging Program at Stanford, Department of Radiology, Stanford University School of Medicine, Stanford, CA, USA.

出版信息

Stem Cell Reports. 2021 Jan 12;16(1):168-181. doi: 10.1016/j.stemcr.2020.11.010. Epub 2020 Dec 17.

DOI:10.1016/j.stemcr.2020.11.010
PMID:33338435
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7897580/
Abstract

Burgeoning applications of human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) in disease modeling, regenerative medicine, and drug screening have broadened the usage of hiPSC-CMs and entailed their long-term storage. Cryopreservation is the most common approach to store hiPSC-CMs. However, the effects of cryopreservation and recovery on hiPSC-CMs remain poorly understood. Here, we characterized the transcriptome, electro-mechanical function, and drug response of fresh hiPSC-CMs without cryopreservation and recovered hiPSC-CMs from cryopreservation. We found that recovered hiPSC-CMs showed upregulation of cell cycle genes, similar or reduced contractility, Ca transients, and field potential duration. When subjected to treatment of drugs that affect electrophysiological properties, recovered hiPSC-CMs showed an altered drug response and enhanced propensity for drug-induced cardiac arrhythmic events. In conclusion, fresh and recovered hiPSC-CMs do not always show comparable molecular and physiological properties. When cryopreserved hiPSC-CMs are used for assessing drug-induced cardiac liabilities, the altered drug sensitivity needs to be considered.

摘要

新兴的人类诱导多能干细胞衍生心肌细胞(hiPSC-CMs)在疾病建模、再生医学和药物筛选中的应用拓宽了 hiPSC-CMs 的用途,并需要对其进行长期储存。冷冻保存是储存 hiPSC-CMs 的最常用方法。然而,冷冻保存及其恢复对 hiPSC-CMs 的影响仍知之甚少。在这里,我们对未经冷冻保存的新鲜 hiPSC-CMs 和从冷冻保存中恢复的 hiPSC-CMs 的转录组、机电功能和药物反应进行了表征。我们发现,恢复的 hiPSC-CMs 中细胞周期基因上调,收缩力、Ca 瞬变和场电位持续时间相似或降低。当用影响电生理特性的药物处理时,恢复的 hiPSC-CMs 表现出改变的药物反应和增强的药物诱导心律失常事件的倾向。总之,新鲜和恢复的 hiPSC-CMs 并不总是表现出相似的分子和生理特性。当使用冷冻保存的 hiPSC-CMs 来评估药物引起的心脏毒性时,需要考虑改变的药物敏感性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/535a/7897580/8e0ebf79ffc1/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/535a/7897580/82cbf83fee70/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/535a/7897580/799b17ed8905/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/535a/7897580/fadcd15b8201/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/535a/7897580/26a275dc81ac/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/535a/7897580/16c221c5c0da/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/535a/7897580/8e0ebf79ffc1/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/535a/7897580/82cbf83fee70/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/535a/7897580/799b17ed8905/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/535a/7897580/fadcd15b8201/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/535a/7897580/26a275dc81ac/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/535a/7897580/16c221c5c0da/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/535a/7897580/8e0ebf79ffc1/gr6.jpg

相似文献

1
Effects of Cryopreservation on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Assessing Drug Safety Response Profiles.冷冻保存对人诱导多能干细胞衍生心肌细胞评估药物安全性反应特征的影响。
Stem Cell Reports. 2021 Jan 12;16(1):168-181. doi: 10.1016/j.stemcr.2020.11.010. Epub 2020 Dec 17.
2
Assessment of Drug Proarrhythmic Potential in Electrically Paced Human Induced Pluripotent Stem Cell-Derived Ventricular Cardiomyocytes Using Multielectrode Array.使用多电极阵列评估电起搏的人诱导多能干细胞衍生的心室心肌细胞中的药物致心律失常潜力。
SLAS Discov. 2021 Mar;26(3):364-372. doi: 10.1177/2472555220953207. Epub 2020 Sep 11.
3
Cryopreservation of human pluripotent stem cell-derived cardiomyocytes is not detrimental to their molecular and functional properties.人多能干细胞衍生心肌细胞的冷冻保存对其分子和功能特性并无损害。
Stem Cell Res. 2020 Mar;43:101698. doi: 10.1016/j.scr.2019.101698. Epub 2020 Jan 7.
4
Engineered heart tissue models from hiPSC-derived cardiomyocytes and cardiac ECM for disease modeling and drug testing applications.基于人诱导多能干细胞(hiPSC)分化的心肌细胞和心脏细胞外基质构建的工程化心脏组织模型,可用于疾病建模和药物测试应用。
Acta Biomater. 2019 Jul 1;92:145-159. doi: 10.1016/j.actbio.2019.05.016. Epub 2019 May 7.
5
The effects of xeno-free cryopreservation on the contractile properties of human iPSC derived cardiomyocytes.无血清冻存对人诱导多能干细胞来源心肌细胞收缩性能的影响。
J Mol Cell Cardiol. 2022 Jul;168:107-114. doi: 10.1016/j.yjmcc.2022.04.010. Epub 2022 Apr 21.
6
Acute effects of cardiac contractility modulation on human induced pluripotent stem cell-derived cardiomyocytes.心肌收缩调节对人诱导多能干细胞衍生心肌细胞的急性影响。
Physiol Rep. 2021 Nov;9(21):e15085. doi: 10.14814/phy2.15085.
7
Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity.利用人诱导多能干细胞衍生的心肌细胞文库进行药物筛选,揭示了毒性的疾病特异性模式。
Circulation. 2013 Apr 23;127(16):1677-91. doi: 10.1161/CIRCULATIONAHA.113.001883. Epub 2013 Mar 21.
8
The electrophysiological effects of cardiac glycosides in human iPSC-derived cardiomyocytes and in guinea pig isolated hearts.强心苷对人诱导多能干细胞衍生心肌细胞和豚鼠离体心脏的电生理作用。
Cell Physiol Biochem. 2011;27(5):453-62. doi: 10.1159/000329966. Epub 2011 Jun 15.
9
Mutation-specific differences in arrhythmias and drug responses in CPVT patients: simultaneous patch clamp and video imaging of iPSC derived cardiomyocytes.CPVT 患者心律失常和药物反应的突变特异性差异:iPSC 衍生心肌细胞的膜片钳和视频成像的同步检测。
Mol Biol Rep. 2020 Feb;47(2):1067-1077. doi: 10.1007/s11033-019-05201-y. Epub 2019 Nov 30.
10
Evaluation of Changes in Morphology and Function of Human Induced Pluripotent Stem Cell Derived Cardiomyocytes (HiPSC-CMs) Cultured on an Aligned-Nanofiber Cardiac Patch.在排列纳米纤维心脏补片上培养的人诱导多能干细胞衍生心肌细胞(HiPSC-CMs)的形态和功能变化评估
PLoS One. 2015 May 19;10(5):e0126338. doi: 10.1371/journal.pone.0126338. eCollection 2015.

引用本文的文献

1
DMSO-free cryopreservation of hiPSC-derived cardiomyocytes: low temperature characterization and protocol development.人诱导多能干细胞来源心肌细胞的无二甲基亚砜冷冻保存:低温特性及方案开发
Stem Cell Res Ther. 2025 Jun 10;16(1):301. doi: 10.1186/s13287-025-04384-5.
2
AI-guided laser purification of human iPSC-derived cardiomyocytes for next-generation cardiac cell manufacturing.用于下一代心脏细胞制造的人工智能引导的人诱导多能干细胞衍生心肌细胞激光纯化
Commun Biol. 2025 May 13;8(1):745. doi: 10.1038/s42003-025-08162-0.
3
DMSO-free cryopreservation of hiPSC-derived cardiomyocytes: Low temperature characterization and protocol development.

本文引用的文献

1
A versatile polypharmacology platform promotes cytoprotection and viability of human pluripotent and differentiated cells.一种多功能多药理学平台促进人类多能性和分化细胞的细胞保护和活力。
Nat Methods. 2021 May;18(5):528-541. doi: 10.1038/s41592-021-01126-2. Epub 2021 May 3.
2
Cryopreservation of human pluripotent stem cell-derived cardiomyocytes is not detrimental to their molecular and functional properties.人多能干细胞衍生心肌细胞的冷冻保存对其分子和功能特性并无损害。
Stem Cell Res. 2020 Mar;43:101698. doi: 10.1016/j.scr.2019.101698. Epub 2020 Jan 7.
3
Patient and Disease-Specific Induced Pluripotent Stem Cells for Discovery of Personalized Cardiovascular Drugs and Therapeutics.
人诱导多能干细胞来源心肌细胞的无二甲基亚砜冷冻保存:低温特性及方案制定
Res Sq. 2025 Apr 14:rs.3.rs-5183739. doi: 10.21203/rs.3.rs-5183739/v1.
4
Cryopreservation practices in clinical and preclinical iPSC-based cell therapies: Current challenges and future directions.基于诱导多能干细胞的临床和临床前细胞治疗中的冷冻保存实践:当前挑战与未来方向。
Biotechnol Prog. 2025 Jul-Aug;41(4):e70031. doi: 10.1002/btpr.70031. Epub 2025 Apr 2.
5
Optimizing cryopreservation strategies for scalable cell therapies: A comprehensive review with insights from iPSC-derived therapies.优化可扩展细胞疗法的冷冻保存策略:基于诱导多能干细胞衍生疗法见解的全面综述
Biotechnol Prog. 2024 Nov-Dec;40(6):e3504. doi: 10.1002/btpr.3504. Epub 2024 Sep 13.
6
Efficient and reproducible generation of human iPSC-derived cardiomyocytes and cardiac organoids in stirred suspension systems.高效且可重现的人诱导多能干细胞衍生心肌细胞和心脏类器官在搅拌悬浮体系中的生成。
Nat Commun. 2024 Jul 15;15(1):5929. doi: 10.1038/s41467-024-50224-0.
7
Hypothermic and cryogenic preservation of cardiac tissue-engineered constructs.心脏组织工程构建体的低温和深低温保存。
Biomater Sci. 2024 Jul 23;12(15):3866-3881. doi: 10.1039/d3bm01908j.
8
Efficient and reproducible generation of human iPSC-derived cardiomyocytes using a stirred bioreactor.使用搅拌式生物反应器高效且可重复地生成人诱导多能干细胞衍生的心肌细胞。
bioRxiv. 2024 Feb 28:2024.02.24.581789. doi: 10.1101/2024.02.24.581789.
9
Systematic cryopreservation study of cardiac myoblasts in suspension.悬浮状态下心肌细胞的系统冷冻保存研究。
PLoS One. 2024 Mar 6;19(3):e0295131. doi: 10.1371/journal.pone.0295131. eCollection 2024.
10
Technical Applications of Microelectrode Array and Patch Clamp Recordings on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.微电极阵列和膜片钳记录在人诱导多能干细胞衍生心肌细胞中的技术应用。
J Vis Exp. 2022 Aug 4(186). doi: 10.3791/64265.
用于发现个体化心血管药物和治疗方法的患者和疾病特异性诱导多能干细胞。
Pharmacol Rev. 2020 Jan;72(1):320-342. doi: 10.1124/pr.116.013003.
4
Identifying the Transcriptome Signatures of Calcium Channel Blockers in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.鉴定钙通道阻滞剂在人诱导多能干细胞衍生心肌细胞中的转录组特征。
Circ Res. 2019 Jul 5;125(2):212-222. doi: 10.1161/CIRCRESAHA.118.314202. Epub 2019 May 13.
5
A Human iPSC Double-Reporter System Enables Purification of Cardiac Lineage Subpopulations with Distinct Function and Drug Response Profiles.人诱导多能干细胞双报告系统可用于分离具有不同功能和药物反应特征的心脏谱系亚群。
Cell Stem Cell. 2019 May 2;24(5):802-811.e5. doi: 10.1016/j.stem.2019.02.015. Epub 2019 Mar 14.
6
Human-Induced Pluripotent Stem Cell Model of Trastuzumab-Induced Cardiac Dysfunction in Patients With Breast Cancer.人诱导多能干细胞模型在乳腺癌患者曲妥珠单抗诱导心脏功能障碍中的应用。
Circulation. 2019 May 21;139(21):2451-2465. doi: 10.1161/CIRCULATIONAHA.118.037357.
7
Development of a Human iPSC Cardiomyocyte-Based Scoring System for Cardiac Hazard Identification in Early Drug Safety De-risking.基于人诱导多能干细胞心肌细胞的评分系统在早期药物安全性风险降低中的心脏毒性鉴定。
Stem Cell Reports. 2018 Dec 11;11(6):1365-1377. doi: 10.1016/j.stemcr.2018.11.007.
8
Experimentally Validated Pharmacoinformatics Approach to Predict hERG Inhibition Potential of New Chemical Entities.预测新化学实体hERG抑制潜力的实验验证药物信息学方法
Front Pharmacol. 2018 Sep 19;9:1035. doi: 10.3389/fphar.2018.01035. eCollection 2018.
9
International Multisite Study of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Drug Proarrhythmic Potential Assessment.国际多中心人类诱导多能干细胞衍生心肌细胞药物致心律失常潜能评估研究。
Cell Rep. 2018 Sep 25;24(13):3582-3592. doi: 10.1016/j.celrep.2018.08.079.
10
Determining the Pathogenicity of a Genomic Variant of Uncertain Significance Using CRISPR/Cas9 and Human-Induced Pluripotent Stem Cells.利用 CRISPR/Cas9 和人诱导多能干细胞确定不确定意义的基因组变异的致病性。
Circulation. 2018 Dec 4;138(23):2666-2681. doi: 10.1161/CIRCULATIONAHA.117.032273.